Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03310281 · ClinicalTrials.gov registry record · NA
Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)
A NA study, sponsored by Akili Interactive Labs.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT03310281: Completed NA study, sponsored by Akili Interactive Labs.
NCT03310281 is a NA study that has completed, run by Akili Interactive Labs. The registered enrollment target is 84 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03310281, a NA study, has completed, sponsored by Akili Interactive Labs.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of videogame-like digital therapies as adjunct therapy to antidepressant medications on cognitive deficits associated with major depressive disorder.
Primary Outcome
Compare scores from the first half of the TOVA measured at DAY0/baseline with scores from the first half of the TOVA measured at DAY42/exit between the two treatment groups.
Interventions
- DEVICE HOLD: Videogame
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2017-12-04 |
| Est. Completion | 2018-11-14 |
| Phase | NA |
What the finished NCT03310281 record still lists
NCT03310281 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which HOLD: Videogame is the first listed.
NCT03310281 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03310281 about?
NCT03310281 is a clinical study titled "Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)". The purpose of this study is to evaluate the effects of videogame-like digital therapies as adjunct therapy to antidepressant medications on cognitive deficits associated with major depressive disorder.
What is the current status of trial NCT03310281?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2017-12-04. Estimated completion is 2018-11-14.
What interventions are being tested in trial NCT03310281?
The interventions under investigation include: HOLD: Videogame (DEVICE).
Who is sponsoring clinical trial NCT03310281?
This trial is sponsored by Akili Interactive Labs, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03310281's enrollment target sits among peer trials
84 983rd of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI